Inhibiting CAV3 isoforms and the delta25B splice varients for the diagnosis and treatment of cancer

Details for Australian Patent Application No. 2012201933 (hide)

Owner University of Virginia Patent Foundation

Inventors Gray, Lloyd S.; Macdonald, Timothy L.

Agent Davies Collison Cave

Pub. Number AU-A-2012201933

Parent 2011203315

Filing date 3 April 2012

Wipo publication date 26 April 2012

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 31/4184 (2006.01)

A61K 31/4422 (2006.01) - 1,4-Dihydropyridines, e.g. nifedipine, nicardipine

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 49/00 (2006.01) Preparations for testing

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

19 April 2012 Complete Application Filed

26 April 2012 Application Open to Public Inspection

  Published as AU-A-2012201933

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012201934-Treatment of Pulmonary disease conditions

2012201932-Systems and methods for delivery of peritoneal dialysis (PD) solutions